OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology-Reference-Cited by-同舟云学术

OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology

Published:2013-09 Issue:9 Volume:30 Page:819-833
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Ginsberg David,Cruz Francisco,Herschorn Sender,Gousse Angelo,Keppenne Véronique,Aliotta Philip,Sievert Karl-Dietrich,Brin Mitchell F.,Jenkins Brenda,Thompson Catherine,Lam Wayne,Heesakkers John,Haag-Molkenteller Cornelia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-013-0054-z

Reference15 articles.

1. Foley SJ, McFarlane JP, Shah PJ. Vesico-ureteric reflux in adult patients with spinal injury. Br J Urol. 1997;79:888–91.

2. Hicken BL, Putzke JD, Richards JS. Bladder management and quality of life after spinal cord injury. Am J Phys Med Rehabil. 2001;80:916–22.

3. Schurch B, de Seze M, Denys P, et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol. 2005;174:196–200.

4. Schurch B, Denys P, Kozma CM, et al. Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. Eur Urol. 2007;52:850–8.

5. Apostolidis A, Thompson C, Yan X, Mourad S. An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity. World J Urol. 2012 (Epub ahead of print).

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies;Toxins;2024-08-05

2. Autonomic dysreflexia in urological practice: pathophysiology, prevention and treatment considerations;World Journal of Urology;2024-02-15

3. Botulinum Toxin Treatment of Bladder and Pelvic Disorders;Botulinum Toxin Treatment;2024

4. Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact;Medicine;2023-07-01

5. Predictors for adverse events following intravesical botulinum toxin injections in men;Neurourology and Urodynamics;2023-06-29